Chop

Dark & Lovely and the College Gurl Foundation Announce New Scholarships for Black, Female College Students

Retrieved on: 
Friday, October 7, 2022

Building Beautiful Futures is a multi-year commitment that will help bring educational and career equity to Black, female college students and young professionals via scholarships, mentorship and career coaching opportunities.

Key Points: 
  • Building Beautiful Futures is a multi-year commitment that will help bring educational and career equity to Black, female college students and young professionals via scholarships, mentorship and career coaching opportunities.
  • "Together, we are championing for education and sprinkling our black girl magic to close the opportunity gap for generations to come!"
  • As a subsidiary of L'Oral USA, Dark & Lovely continues to unveil breakthrough hair innovations for women of color.
  • Since 2017, The College Gurl Foundation (CGF) has been educating students with a focus on minority students in the Washington Metropolitan area who come from economically disadvantaged households.

Children's Hospital of Philadelphia (CHOP) Announces 100th Home Repair to Address Asthma Triggers in Patients' Homes

Retrieved on: 
Monday, February 7, 2022

PHILADELPHIA, Feb. 7, 2022 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced the completion of its 100th home renovation for families enrolled in the Community Asthma Prevention Plus (CAPP+) Program .

Key Points: 
  • PHILADELPHIA, Feb. 7, 2022 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) today announced the completion of its 100th home renovation for families enrolled in the Community Asthma Prevention Plus (CAPP+) Program .
  • CAPP+ partners with community organizations and minority-owned business owners to address asthma triggers for families from CHOP's Community Asthma Prevention Program who own homes in West Philadelphia.
  • The CAPP+ program recently expanded and is now offering repairs to CAPP families who are renters, with landlord approval.
  • About Children's Hospital of Philadelphia:Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

DARK & LOVELY LAUNCHES NEW INITIATIVE: BUILDING BEAUTIFUL FUTURES

Retrieved on: 
Wednesday, January 19, 2022

Actress, producer,"artivist" and Dark & Lovely brand ambassador, Storm Reid will lend her voice to help inspire and uplift young women throughout the program.

Key Points: 
  • Actress, producer,"artivist" and Dark & Lovely brand ambassador, Storm Reid will lend her voice to help inspire and uplift young women throughout the program.
  • "Now more than ever, young Black women are in need of actionable support that can propel them forward," said Erica Culpepper, General Manager, Dark & Lovely.
  • Dark & Lovely and the NAACP have had a long history of supporting women of color via scholarships and mentorship.
  • Dark & Lovely, founded in 1972, was created to help Black women express and embrace their individual styles.

Children's Hospital of Philadelphia Launches Innovative Virtual Teen Driving Assessment Program with $4 Million Grant from NJM Insurance Group

Retrieved on: 
Tuesday, June 8, 2021

The implementation of the VDAS program is a collaboration among CHOP Care Network Operations, CIRP, and The Possibilities Project at CHOP.

Key Points: 
  • The implementation of the VDAS program is a collaboration among CHOP Care Network Operations, CIRP, and The Possibilities Project at CHOP.
  • With the virtual driving assessment, we can help them to successfully and safely navigate through early driving."
  • "In 2017, NJM expanded its award-winning teen driving safety program to include Share the Keys, a research-based, data-driven program designed to reduce teen driver crash risks through increased parental involvement.
  • About Children's Hospital of Philadelphia: Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

InnoCare Announces Approval of Orelabrutinib in Combination with R-CHOP as First-Line Therapy for Mantle Cell Lymphoma in China

Retrieved on: 
Friday, February 5, 2021

This is a phase 3 multicenter, randomized trial of orelabrutinib in combination with R-CHOP versus placebo plus R-CHOP in previously untreated MCL patients.

Key Points: 
  • This is a phase 3 multicenter, randomized trial of orelabrutinib in combination with R-CHOP versus placebo plus R-CHOP in previously untreated MCL patients.
  • In addition, orelabrutinib combined with R-CHOP will also be used to treat patients with other B-cell malignant lymphomas.
  • MCL is typically an aggressive form of non-Hodgkins lymphoma (NHL) that arises from B-cells originating in the mantle zone.
  • We strategically focus on lymphoma, solid tumors, and autoimmune diseases with high unmet medical needs in China and worldwide.

Children's Hospital of Philadelphia Appoints Donald Moore as Senior Vice President of Real Estate, Facilities and Operations

Retrieved on: 
Thursday, February 4, 2021

PHILADELPHIA, Feb. 4, 2021 /PRNewswire/ --Children's Hospital of Philadelphia (CHOP) has appointed Donald E. Moore as its Senior Vice President of Real Estate, Facilities and Operations.

Key Points: 
  • PHILADELPHIA, Feb. 4, 2021 /PRNewswire/ --Children's Hospital of Philadelphia (CHOP) has appointed Donald E. Moore as its Senior Vice President of Real Estate, Facilities and Operations.
  • "We are pleased to welcome Donald to the CHOP family," said Doug Hock, Executive Vice President and System Chief Operating Officer at Children's Hospital of Philadelphia.
  • Prior to Drexel, Moore served as Senior Vice President for Facilities, Planning and Operations at Rowan University for six years.
  • About Children's Hospital of Philadelphia:Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

Attorney Ben Crump: Bayer Seeks to Profit Both from Sale of Weedkiller Linked to Non-Hodgkin's Lymphoma and Drug to Treat it

Retrieved on: 
Monday, October 19, 2020

ST. LOUIS, Oct. 19, 2020 /PRNewswire/ -- Renowned personal injury and civil rights attorney Ben Crump today denounced Bayer Corporation for seeking to profit both from the sale of its weedkiller Roundup, which has been linked to non-Hodgkins lymphoma, and a new Bayer drug to treat the disease.

Key Points: 
  • ST. LOUIS, Oct. 19, 2020 /PRNewswire/ -- Renowned personal injury and civil rights attorney Ben Crump today denounced Bayer Corporation for seeking to profit both from the sale of its weedkiller Roundup, which has been linked to non-Hodgkins lymphoma, and a new Bayer drug to treat the disease.
  • On Oct. 14, Bayer announced the Phase III study results of its new drug copanlisib in combination with rituximab in patients with relapsed indolent non-Hodgkin's lymphoma.
  • "Bayer has assured itself a continuing stream of business for its non-Hodgkin's lymphoma drug by fighting to keep the deadly weedkiller Roundup on the market."
  • "Bayer has demonstrated a pattern of putting profits over people, with blatant disregard for human life," said attorney Chris Schnieders.

Rituximab Biosimilars Landscape Report 2020 Featuring 34 Key Players & 30 Key Products - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 8, 2020

The "Rituximab - Biosimilars Insight, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Rituximab - Biosimilars Insight, 2020" report has been added to ResearchAndMarkets.com's offering.
  • This Rituximab- Biosimilar Insight, 2020 report provides comprehensive insights about 35+ companies and 35+ marketed and pipeline drugs in Rituximab Biosimilars landscape.
  • This segment of the report provides insights about the different Rituximab biosimilars segregated based on following parameters that define the scope of the report, such as:
    There are approx.
  • Rituximab pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Children's Hospital of Philadelphia Recognized as a Leader in "Best Places to Work for Disability Inclusion"

Retrieved on: 
Wednesday, July 15, 2020

PHILADELPHIA, July 15, 2020 /PRNewswire/ --Children's Hospital of Philadelphia (CHOP)is proud to be recognized for the 2ndyear in a row by the Disability Equality Index (DEI) as a leader in "Best Places to Work for Disability Inclusion."

Key Points: 
  • PHILADELPHIA, July 15, 2020 /PRNewswire/ --Children's Hospital of Philadelphia (CHOP)is proud to be recognized for the 2ndyear in a row by the Disability Equality Index (DEI) as a leader in "Best Places to Work for Disability Inclusion."
  • The DEI is the nation's most comprehensive annual benchmarking tool used to survey employers' disability policies, practices and initiatives.
  • CHOP also received a 100 out of 100 score and ranked as a top-rated organization for the second straight year.
  • Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

2019 Carousel Ball Raises Record-Breaking $3.5 Million for the Cardiac Center at Children's Hospital of Philadelphia

Retrieved on: 
Monday, October 14, 2019

PHILADELPHIA, Oct. 14, 2019 /PRNewswire/ -- Children's Hospital of Philadelphia's (CHOP) 2019 Carousel Ball , presented by Wawa, raised a record-breaking $3.5 million to benefit the Cardiac Center at CHOP.

Key Points: 
  • PHILADELPHIA, Oct. 14, 2019 /PRNewswire/ -- Children's Hospital of Philadelphia's (CHOP) 2019 Carousel Ball , presented by Wawa, raised a record-breaking $3.5 million to benefit the Cardiac Center at CHOP.
  • The event was held at the Met Philadelphia, a recently renovated historic opera house on North Broad Street.
  • "The Carousel Ball is always a very special evening of celebration and gratitude," said Madeline Bell, President and CEO of Children's Hospital of Philadelphia.
  • "On behalf of the Cardiac Center, I'd like to thank all of the Carousel Ball sponsors, co-chairs, committee members and the Wood family," said Dr. Jonathan Chen, Chief of the Division of Cardiothoracic Surgery and Co-Director of the Cardiac Center at Children's Hospital of Philadelphia.